NEJM July 8, 2021
Carter Dredge, MHA & Stefan Scholtes, PhD

Leaders at Civica Rx have developed a potentially disruptive health care business model that enables private-sector efficiency and public-sector societal equity at scale.

Summary

The growth of the Civica Rx health care utility model of addressing shortages of pharmaceutical supplies for hospitals has been gathering momentum since its launch in 2018. The concept is to bypass the major drug makers and to manufacture or subcontract for generic pharmaceuticals that its 1,400-plus member hospitals need. What’s unique about the venture is that it is established as a nonstock, nonprofit 501(c)(4) social welfare organization. The money to run the operation comes from the customers (the hospitals) and philanthropic...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Pharma, Pharma / Biotech, Provider
Hospital mergers are leading to higher prices. Will regulators step in?
UCSF Health breaks ground on $4.3B hospital
AtlantiCare CEO discusses expansion, teaming with Cleveland Clinic and Oracle, and more
Kaiser Permanente medical school appoints dean and CEO, and more | MED MOVES
Council Post: How Healthcare Leaders Can Proactively Identify And Address Employee Burnout

Share This Article